Cargando…
P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA.
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429225/ http://dx.doi.org/10.1097/01.HS9.0000848036.19417.16 |
| _version_ | 1784779372883869696 |
|---|---|
| author | Sims, M. Ward, G. Zhang, Z. Jueliger, S. Davis, M. Boxall, A. Taylor, J. Biondo, A. Lyons, J. Smyth, T. |
| author_facet | Sims, M. Ward, G. Zhang, Z. Jueliger, S. Davis, M. Boxall, A. Taylor, J. Biondo, A. Lyons, J. Smyth, T. |
| author_sort | Sims, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429225 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292252022-08-31 P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. Sims, M. Ward, G. Zhang, Z. Jueliger, S. Davis, M. Boxall, A. Taylor, J. Biondo, A. Lyons, J. Smyth, T. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429225/ http://dx.doi.org/10.1097/01.HS9.0000848036.19417.16 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Sims, M. Ward, G. Zhang, Z. Jueliger, S. Davis, M. Boxall, A. Taylor, J. Biondo, A. Lyons, J. Smyth, T. P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. |
| title | P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. |
| title_full | P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. |
| title_fullStr | P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. |
| title_full_unstemmed | P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. |
| title_short | P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. |
| title_sort | p1293: combining the iap antagonist, tolinapant, with a dna hypomethylating agent enhances anti-tumour mechanisms in preclinical models of t-cell lymphoma. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429225/ http://dx.doi.org/10.1097/01.HS9.0000848036.19417.16 |
| work_keys_str_mv | AT simsm p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma AT wardg p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma AT zhangz p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma AT jueligers p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma AT davism p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma AT boxalla p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma AT taylorj p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma AT biondoa p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma AT lyonsj p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma AT smytht p1293combiningtheiapantagonisttolinapantwithadnahypomethylatingagentenhancesantitumourmechanismsinpreclinicalmodelsoftcelllymphoma |